FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 27 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $15,061 | -20.3% | 2,451 | +43.9% | 0.00% | – |
| Q1 2024 | $18,895 | -1.1% | 1,703 | 0.0% | 0.00% | – |
| Q4 2023 | $19,099 | +70.7% | 1,703 | +14.0% | 0.00% | – |
| Q3 2023 | $11,190 | -34.5% | 1,494 | -22.9% | 0.00% | – |
| Q2 2023 | $17,074 | +13.8% | 1,938 | -21.6% | 0.00% | – |
| Q1 2021 | $15,000 | -25.0% | 2,473 | -8.9% | 0.00% | – |
| Q4 2020 | $20,000 | +25.0% | 2,716 | 0.0% | 0.00% | – |
| Q3 2020 | $16,000 | -46.7% | 2,716 | -23.6% | 0.00% | – |
| Q2 2020 | $30,000 | +328.6% | 3,557 | +111.6% | 0.00% | – |
| Q2 2019 | $7,000 | -12.5% | 1,681 | 0.0% | 0.00% | – |
| Q1 2019 | $8,000 | -27.3% | 1,681 | 0.0% | 0.00% | – |
| Q4 2018 | $11,000 | -21.4% | 1,681 | 0.0% | 0.00% | – |
| Q3 2018 | $14,000 | -22.2% | 1,681 | 0.0% | 0.00% | – |
| Q2 2018 | $18,000 | – | 1,681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 2,407,357 | $21,256,962 | 14.19% |
| Solas Capital Management, LLC | 1,439,028 | $12,706,617 | 8.46% |
| DG Capital Management, LLC | 1,074,654 | $9,489,195 | 4.23% |
| HARBERT FUND ADVISORS, INC. | 466,869 | $4,122,453 | 2.31% |
| AIGH Capital Management LLC | 349,457 | $3,085,705 | 1.26% |
| APIS CAPITAL ADVISORS, LLC | 90,000 | $794,700 | 0.80% |
| Southpoint Capital Advisors LP | 4,077,214 | $36,001,800 | 0.78% |
| Worth Venture Partners, LLC | 93,252 | $823,415 | 0.45% |
| Lion Point Capital, LP | 110,000 | $971,300 | 0.44% |
| GENDELL JEFFREY L | 283,413 | $2,502,537 | 0.19% |